GlassScriptPhysician profile
Michael J Young
NPI 1750395125
$3,806.81
in general payments reported to CMS, 2019-2025
20 companies · $2,015 in 2025
The $2,015 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.60 · 2022: $338 · 2023: $403 · 2024: $969 · 2025: $2,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,387.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,121.58 | 2021-2025 | Reunion, Aequalis Flex Revive, Pangea |
| Sanara Medtech INC. | $174.13 | 2025 | Celleraterx |
| Amgen INC. | $67.40 | 2021-2023 | Prolia, Evenity |
| Merz Pharmaceuticals, LLC | $62.09 | 2023 | Xeomin |
| Si-Bone, INC. | $59.71 | 2022-2023 | |
| Collegium Pharmaceutical, INC. | $49.65 | 2022-2023 | Belbuca |
| Coastal Medical Technologies LLC | $31.41 | 2023-2024 | |
| Smith+Nephew, INC. | $26.15 | 2025 | Evos |
| Medtronic, INC. | $24.56 | 2023 | Intellis Adaptivestim |
| Fidia Pharma USA INC. | $24.15 | 2022 | |
| Abbvie INC. | $20.82 | 2022 | |
| Arteriocyte Medical Systems, INC. | $20.56 | 2023 | Magellan |
| Ermi LLC | $20.21 | 2025 | |
| Endo USA, INC. | $19.46 | 2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $17.95 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $17.02 | 2022 | |
| Merck Sharp & Dohme LLC | $13.15 | 2022 | |
| Pacira Therapeutics, INC. | $12.85 | 2021 | |
| Bioventus LLC | $12.50 | 2022 | |
| Stimwave Technologies Incorporated | $11.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.